Everyday Health names ABC News exec to lead video efforts

Share this article:
Paul Slavin
Paul Slavin
Everyday Health hired an ABC News exec to head up its health video and global news efforts.

Paul Slavin, who was SVP for new media at ABC News, in charge of all of the Disney unit's digital content, mobile and broadband communications, becomes SVP general manager, global news and Everyday Health Studios. He assumes responsibility for expanding news operations, including the new Everyday Health Studios video unit, and reports to EVP/chief product officer Goli Sheikholesiami.

“Our commitment to using video to expand our reach to a greater number of health consumers is clearly demonstrated with the addition of paul, who has been instrumental in the digital success of ABC News,” said Sheikholesiami in a statement. “He will play a key role in developing projects such as our new Everyday Health television series and work on other groundbreaking ideas.”

Slavin spent 33 years at ABC News, serving as executive producer of “World News Tonight With Peter Jennings” and SVP worldwide newsgathering before overseeing a shakeup of the New Media business unit that made it profitable. At Everyday Health, he is tasked with bolstering video production across the company's portfolio of brands, including EverydayHealth.com, MedPage Today and DailyGlow.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...